ABC News July 7, 2022

Former Theranos executive Sunny Balwani convicted in criminal fraud case

WATCH: Former Theranos executive Sunny Balwani convicted of fraud

A jury has convicted former Theranos president Ramesh “Sunny” Balwani of defrauding investors and patients in connection with his multi-billion-dollar blood-testing startup.

Balwani, on Thursday, was found guilty on all 12 counts of fraud, for a scheme prosecutors alleged and have now proved he orchestrated alongside his former romantic partner and Theranos Founder Elizabeth Holmes.

Balwani faced 10 counts of wire fraud and two counts of conspiracy to commit wire fraud.

Holmes, who faced the same charges as Balwani, was convicted on four counts of fraud in January and awaits sentencing in September.

While Holmes was only convicted on counts related to investors, a jury found Balwani also defrauded patients.

The feds originally charged Balwani and Holmes together. But their trials were later severed after Holmes revealed she may testify to abuse at the hands of Balwani.

Prosecutors said Balwani and Holmes, who touted her startup's technology as capable of accurately and reliably running any blood test, fraudulently raised hundreds of millions of dollars from investors.

Money poured in, but the miniature blood-testing device, dubbed the "Edison," could never run more than 12 tests, government attorneys said.

Balwani joined the company in 2009, guaranteeing a $10 million loan and quickly rising to the post of president and COO of Theranos. While his attorneys sought to distinguish his position in the company from the CEO, Holmes, prosecutors say he played an equal role in the fraud.

MORE: Theranos founder Elizabeth Holmes convicted on 4 counts of fraud
Justin Sullivan/Getty Images, FILE
Former Theranos founder and CEO Elizabeth Holmes arrives at the Robert F. Peckham U.S. Federal Court, April 22, 2019, in San Jose, Calif.

"I am responsible for everything at Theranos. All have been my decisions too," read a text message from Balwani to Holmes in July 2015, which Assistant U.S. Attorney Jeff Schenk presented to the jury in his final argument.

"Of course [Balwani] had a hand in making the decisions at Theranos," defense attorney Jeff Coopersmith said during his closing argument.

But, Coopersmith, said in meetings with investors and others, "everyone was listening to Elizabeth Holmes." The company was her vision, he added, and Balwani had bought in.

"Mr. Balwani is not a victim. He's a perpetrator of the fraud," the prosecutor, Schenk, said to wrap up his remarks.

Yichuan Cao/Sipa USA via AP, FILE
Ramesh Balwani of Theranos arrives for motion hearing, Nov. 4, 2019, at the U.S. District Court House inside Robert F. Peckham Federal Building in San Jose, Calif.
MORE: Trial of Theranos executive Sunny Balwani to begin

Wayne Kaatz, a juror on the Holmes case, told ABC News in an exclusive interview earlier this year that his group of 12 jurors convicted Holmes, in part, because "everything went through her," he said. "She had final approval."

He also revealed his team found Holmes' testimony largely not credible. Balwani, in his trial, did not take the stand.

Wayne Kaatz, a juror on the Holmes case, told ABC News in an exclusive interview earlier this year that his group of 12 jurors convicted Holmes, in part, because "everything went through her," he said. "She had final approval."

He also revealed his team found Holmes' testimony largely not credible. Balwani, in his trial, did not take the stand.

For the full backstory on Balwani, Elizabeth Holmes and Theranos, listen to ABC News' podcast “The Dropout.”

[

]